Lefamulin Now Available for Community-Acquired Bacterial Pneumonia

The oral and IV formulations of Xenleta (lefamulin), a first-in-class pleuromutilin antibiotic, have been made available in the US by Nabriva Therapeutics.

Lefamulin Now Available for Community-Acquired Bacterial Pneumonia
QR Code
Embed the QR code on your website:
Download
Copy